https://eloralintideresearch.com/news/eloratzp-phase-2b-readout/2026-10-02T14:18:28+00:00https://eloralintideresearch.com/news/eloratzp-phase-2-study-start-2024/2026-10-02T10:54:03+00:00https://eloralintideresearch.com/news/phase-1-pharmacokinetics-study-2025/2026-10-02T10:54:03+00:00https://eloralintideresearch.com/news/phase-2-obesity-trial-primary-completion/2026-10-02T10:54:03+00:00https://eloralintideresearch.com/news/molecular-metabolism-discovery-paper/2026-10-02T10:54:03+00:00https://eloralintideresearch.com/news/macupatide-eloralintide-phase-2-type-2-diabetes/2026-10-02T10:54:03+00:00https://eloralintideresearch.com/news/lilly-announces-eloralintide-phase-2-results/2026-10-02T10:54:04+00:00https://eloralintideresearch.com/news/lancet-eloralintide-phase-2-paper/2026-10-02T10:54:04+00:00https://eloralintideresearch.com/news/phase-3-eloralintide-type-2-diabetes-start/2026-10-02T10:54:04+00:00https://eloralintideresearch.com/news/phase-1-multiple-dose-paper/2026-10-02T10:54:04+00:00https://eloralintideresearch.com/news/enlighten-1-phase-3-start/2026-10-02T10:54:05+00:00https://eloralintideresearch.com/news/enlighten-4-knee-osteoarthritis-phase-3/2026-10-02T10:54:05+00:00https://eloralintideresearch.com/news/phase-3-obstructive-sleep-apnea-program/2026-10-02T10:54:05+00:00https://eloralintideresearch.com/news/phase-3-persistent-obesity-weekly-incretin/2026-10-02T10:54:05+00:00https://eloralintideresearch.com/news/peptides-review-long-acting-amylin-analogues/2026-10-02T10:54:05+00:00https://eloralintideresearch.com/news/petrelintide-zupreme-1-phase-2-results/2026-10-02T10:54:06+00:00https://eloralintideresearch.com/news/network-meta-analysis-amylin-based-therapies/2026-10-02T10:54:06+00:00https://eloralintideresearch.com/news/macupatide-eloralintide-phase-2b-without-diabetes/2026-10-02T10:54:06+00:00https://eloralintideresearch.com/news/ada-2026-eloralintide-tirzepatide-rat-poster/2026-10-02T10:54:06+00:00https://eloralintideresearch.com/news/zenagamtide-phase-2-type-2-diabetes/2026-10-02T10:54:07+00:00https://eloralintideresearch.com/news/dom-review-amylin-analogs-next-major-class/2026-10-02T10:54:07+00:00https://eloralintideresearch.com/news/pharmacological-research-amylin-tolerability-review/2026-10-02T10:54:07+00:00https://eloralintideresearch.com/news/lilly-easd-2026-eloratzp-preview/2026-10-02T14:18:28+00:00https://eloralintideresearch.com/news/cardiology-in-review-eloralintide-cardiometabolic/2026-10-02T10:54:07+00:00